Duloxetine may cause akathisia

Duloxetine, marketed under the brand names of Cymbalta and Yentreve, may be associated with the development of akathisia, characterised by restlessness and an inability to sit or stand still.

Doctors are advised that in patients who develop these symptoms increasing the dose may be detrimental and that it may be necessary to review the use of the drug. If therapy does need to be withdrawn, it should be done gradually.

Further information: Lilly, Lilly House, Priestley Road, Basingstoke, Hants RG24 9NL. Tel: (01256) 315000.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more